From a conversation with UBi to measured treatment response
A patient with ulcerative colitis completes a guided voice check-in. Stool frequency relative to her usual baseline and rectal bleeding calculate a Mayo-derived UC PRO2 score, which is tracked alongside objective biomarkers. UBi connects reported and measured information, coordinates confirmatory testing under the GI's standing orders, and prepares a nurse-reviewed brief. The GI adjusts the plan and the response is followed over six months.
GI practice EMR
Care-team update for the patient's GI
Gastroenterology
GI practice EMR
P
Patient record
IBD care program
Overview
Results
Clinical review
Care plan
Care-team update
From UBi and the nursing team
Treatment plan adjusted
Directed by the patient's gastroenterologist
Biology over time
One patient, followed across six months
Week 4
Subjective biomarkers
Validated ePRO · ulcerative colitis
UC PRO2
3
/6
2 + 1
Mayo-derived · lower is better
Stools /24h
6
Patient's usual: 2 /24h
Rectal bleeding
1 /3
Streaks in fewer than half
Objective biomarkers
Fecal calprotectin
460 µg/g
Individual target
Month 0
3
6
HRV + activity
4.6 /10
Weight
70.4 kg
Intervention begun
My Health · actual app screen
Clinical brief
UBi
Increased risk flagged
Treatment response
needs attention.
Validated ePRO and biomarker trends
UC PRO2 (Mayo-derived)
3 /6
Stool frequency + bleeding
2 + 1
Calprotectin
Rising trend
Confirmatory test
Fecal calprotectin
Ordered under GI standing orders
Nurse reviewed
ePRO scores and measured evidence
Ready for the patient's GI
At-home collection
Test arranged
Expected update missing
Follow-up needed
New calprotectin result
780
µg/g
Stool frequency: 2 /3
6 in 24h · usual baseline 2
Rectal bleeding: 1 /3
Streaks in fewer than half
UC PRO2
3 /6
Calculated from both responses
Six times in the last day.
Usually, it's twice.
Any blood in those
stools?
Streaks, in less
than half.
How are you
feeling now?
I'm feeling much better.
Speaking with UBi
Following the response to treatment
0:00 / 0:40
Pause
